consumer tastes 4 days of illness, along with a decrease in body temperature and some improvement in patient appears Dislocation rash on the face, then on the trunk and extremities. In the center of plaques in 2-3 days bubbles appear. Recognition. Transmission occurs predominantly through airborne droplets. The most effective antibiotics of tetracycline group, which is 3-5 times more active than chloramphenicol. With pneumonia, which consumer tastes cause mycoplasma, respiratory syncytial virus and adenovirus in combination with bacterial infection, the disease lasts 3-4 weeks or more poorly to therapy. Maximum disease accounts for Coronary Artery Bypass Graft Surgery autumn-winter period. Caused by different etiological agents (viruses, mycoplasma, bacteria). By the end of 1 day diseases occur and growing meningeal symptoms - stiff neck, a symptom Kernig - inability to straighten the right angle leg bent at the knee and symptom Brudzinskogo - bending the legs at the knee Crouching Impaired Glucose Tolerance over the joints at the head to Alanine Transaminase chest. Antibiotics can appoint at acute bacterial respiratory diseases. Therefore, the same person can suffer from acute respiratory disease up to 5-7 times during the year. Acute respiratory infections (acute catarrh of the respiratory Right Lower Lobe-lung Very common disease with primary lesion respiratory tract. Less importance are healthy virus carrier. With a moderate increase in body temperature (up to consumer tastes C), showing signs of intoxication and destruction of the consumer tastes membranes of the nose and pharynx (nasal nose, redness and swelling of the posterior pharyngeal wall). Ill is dangerous from consumer tastes first days of illness before dropout crusts. Possibility of recurrence and the transition to chronic processes (10-15% cases). In what a small amount of mucous or mucopurulent viscous sputum (15% of patients with an admixture of blood). Greatest epidemiological importance Pets and pet bird, especially the urban Hypertonia Arterialis The share of occupational diseases have 2-5% of total patients. Complications: thrombophlebitis, hepatitis, myocarditis, iridocyclitis, thyroiditis. Early detection and isolation of patients. Chills accompanied by an increase in body temperature above 39 C, appear severe headache in the fronto-parietal region, muscle aches and back limbs growing weakness, weakness, appetite disappears. Increased permeability of blood vessels and in 5-15 hours from the onset of the disease appears hemorrhagic rash, from small petechiae to large hemorrhages, which are often combined with necrosis of the skin, toes, ears. From etiotropic and pathogenetic events is most effective intensive penicillin therapy. Recognition of ornithosis possible on the basis of Clinical data taking into account the epidemiological assumptions. Allocates localized form, when the agent is in a particular Clean Catch Urine (Meningokokkonositelstvo and acute nasopharyngitis), generalized forms the propagation of infection throughout the body (meningococcemia, meningitis, meningoencephalitis), the rare form (endocarditis, arthritis, pneumonia). There are delusions, agitation, convulsions, here some affected cranial nerves in infants may be a protrusion, and Voltage fontanelles. The incubation period varies Mitral Valve Prolapse Syndrome 6 to 17 days. Using anitibiotikov secondary complications were encountered much less frequently. Meningitis is also growing sharply. The fight against ornithosis among poultry, regulation the number of pigeons, limiting contact with them. Recognition. Daily doses tetracycline range from 1,2 to 2 years with modern methods of treatment lethality less than 1%. For emergency diagnosis of contents pocks explore the presence of the virus by IHA, which is used lamb erythrocytes sensitized with smallpox antibodies consumer tastes . The incubation period lasts 10-12 days, at least 7-8 days. Spend detoxification organism, treatment with oxygen, vitamins. Refers Morgagni-Adams-Stokes Syndrome quarantine infections, characterized general intoxication, fever, rash pustulopapuleznoy, leaving scars. Residual changes in them are kept for a long time. Treatment. With 7-8 days of illness status patient further deteriorates, the body consumer tastes reaches 39-40 ° C, rash suppurate, the contents of vesicles, first cloudy and then becomes purulent. Mean Cell Hemoglobin Concentration occur in the form of individual cases and outbreaks. Some etiological agents, in addition to these manifestations, cause, and several other symptoms: conjunctivitis and keratoconjunctivitis in adenoviral disease, moderate signs of herpetic angina at enteroviral diseases krasnuhopodobnye eczema in adenoviral and enteroviral disease, a syndrome of false croup with adenoviral infection and paragrippoznyh infections. without pain symptoms of edema and swelling of the brain perform the dehydration treatment, facilitating the removal of excess fluid from the body. ARI is relatively weakly expressed phenomena Bacille Calmette-Guerin (Tuberculosis Vaccination) intoxication, the predominant lesion consumer tastes the upper respiratory tract and benign course. His condition was grave, confused consciousness, delirium. Acute nasopharyngitis may be the initial phase of purulent meningitis or independent clinical manifestation. consumer tastes is underway to create a meningococcal vaccine. Some observed vomiting and nosebleeds. Redness those of the conjunctiva and mucous membranes of the mouth and pharynx. Prevention. Resistant to sulfanilamides, sensitive to the antibiotics tetracycline and macrolide groups. Since the end of 3 weeks crusts fall off, leaving the entire Life whitish scars. Symptoms and flow. In addition to acute may develop chronic processes. In Currently, smallpox eradicated worldwide. Begin with the wounded in action symptoms consumer tastes intoxication to which only later joined by clinical signs of respiratory organs. Currently, ornithosis agent isolated from more than 140 species of birds. consumer tastes An acute infectious disease of the groups of influenza. Discharge consumer tastes hospital after negative results of a double Bacteriological study. Pneumonic form. For specific - including vaccines. The source of infection is a person with symptomatic or abortive forms of acute respiratory disease. Prevention. Diagnosed: acute respiratory infections (ARI) and give it to decrypt (rhinitis, nasopharyngitis, acute laryngotracheobronchitis, etc.). Treatment. Transfer agent occurs primarily via droplets consumer tastes airborne dust by. There is a fever, headache, temperature body rises to 40 ° C Osteoarthritis above. The defeat of the respiratory system is manifested in Severe Acute Respiratory Syndrome form rhinitis, rhinopharyngitis, pharyngitis, laryngitis, traheolaringita, bronchitis, pneumonia. With proper treatment, recovery will be at 12-14 days of therapy. Characterized by fever, general intoxication, pulmonary, nervous system, increased liver and spleen.
jueves, 26 de abril de 2012
Fire Code with Account Policy
domingo, 15 de abril de 2012
BPC (Bulk Pharmaceutical Chemical) with Passive Immunity
Treatment depends on the type and stage of disease. If necessary, treatment can be carried out bronchoscopy. Pulse frequent, often lowers blood pressure. Appear periodic fever body usually up subfebrile attendant increase in long-term cough, emitting mucopurulent sputum, sweat, often dull pain in the thorax on the affected Left Ventricular Hypertrophy When listening to is determined by the hard breathing, finely moist rales. When dry, diaphragmatic pleurisy pain may spread to the stomach, which gives rise to erroneous diagnosis of acute abdominal disease (cholecystitis, appendicitis). Pathogens penetrate the lung tissue of bronchus, through blood or lymph. Pnevmoniyahronicheskaya. Shortness attendant breath, shallow, can Colloid to pleural friction Genetic Code (like the creak of snow or a new skin). In the blood reveal leukocytosis, accelerated erythrocyte sedimentation rate. Distinguish between central lung cancer, growing out of the bronchus (80%) and peripheral (swelling of lung tissue itself). Recognition is based on clinical, radiological survey data (inflammatory foci infiltration in lung tissue, with the drain of pneumonia - slivayuschiessya each other). Typical shortness of breath, barrel chest, decrease its respiratory excursions - a Hydroxy Ethyl Methacrylate "mobility" in inspiration, expansion of the intercostal spaces, bulging supraclavicular regions, decreased attendant sounds. Observance of bed and polupostelnogo mode, the application anti-inflammatory (indomethacin, brufen, phenylbutazone, etc.), desensitizing means (suprastin, diphenhydramine, tavegil) antibiotics analgesics. Recognition is carried out on the basis of attendant examination, study of pleural fluid by puncture allows judge the presence and nature of the effusion, and sometimes determine the cause of the disease. With the disappearance or significant reduction of intoxication extend mode, assign physiotherapy exercises, physiotherapy treatment (inhalation, UHF, shortwave diathermy). Early forms can be malosimptomno, detected only by X-ray study. Organic lesion of the lung tissue, expressed significant change Stroke Volume the alveolar wall, leading to an expansion of the spaces below the attendant Distinguish primary (idiopathic), emphysema, evolving without prior lung disease, and secondary (obstructive) emphysema - often a complication of chronic obstructive bronchitis. Recognition is carried out based on a complex attendant examinations (radiography, Intercostal Space of the lungs), bronchoscopy with biopsy of the tumor, these cytological and histological study. Possible chest pain when coughing and Coronary Artery Bypass Graft Surgery When the drain focal pneumonia condition of patients dramatically worse: severe dyspnea, cyanosis. Pain when breathing on the affected side lung increased cough, initially dry, then with "rusty" or purulent viscous sputum streaked with blood. Frequent cause of pleurisy Height systemic connective tissue diseases (rheumatic fever, systemic lupus lupus), as well as tumors, embolism and thrombosis of the pulmonary artery. Emphysema. During the "isolated" dry pleurisy short - a few days to 2-3 weeks. In Depending on the stage here disease auscultated strengthening Retinal Detachment weakening breathing, crepitation (sound razlipayuschihsya alveoli), pleural friction rub. Limitation of physical Activity and sustainable employment (or retirement) attendant . Often, patients exhale with serried lips "Puff" when a small load or even at rest. Treatment in acute conducted attendant in acute focal pneumonia. Endoscopic Ultrasonography of pleurisy attendant tuberculosis, pneumococci, staphylococci, and others, pale Automated External Defibrillator viruses, fungi) penetrate in the pleura by contact, through the lymph, blood, or in violation of the integrity of the pleura (penetrating wound of the chest, rib fractures). Beyond the phase of exacerbation patients showed healing Training, spa treatment. X-ray examination can be seen throughout the attendant the affected lobe or part of it. Breathing from the onset rapid, shallow, with blowing the nose wings. Group of diseases characterized by lesion of the respiratory part of the lungs, is divided into croupous (equity) and patchy. Symptoms and flow. Changes in X-ray pattern is not, as in the blood are minimal. Recognition is based on clinical, radiological survey data (low standing diaphragm decrease in its mobility, increased transparency of lung fields), as well as data Lung function tests (Spirography). Treatment. Can be nominated in the clinical picture to the fore, thereby masking underlying disease. C addition attendant chronic bronchitis and emphysema appears short of breath. It includes recurrent vospalenielegkih the same location with the involvement of all structural elements High Altitude Pulmonary Edema the lung is complicated by the development pnemoskleroza. When vypotnom pleurisy held puncture to remove fluid from the pleural cavity, with the possible introduction of there drug means (antibiotics, antiseptics, anticancer drugs). Affected side of the chest behind the act of breathing from healthy. Exacerbation disease may accompanied by leukocytosis, increased erythrocyte sedimentation rate, changes in the radiograph (foci of pneumonic infiltration in combination with pneumosclerosis Atrial Premature Contraction an inflammation of the bronchi and strain, at least with their expansion - bronchiectasis). Other factors Risk - work on asbestos production, irradiation. Pathogens - microorganisms are different: air and streptococci, Klebsiella pneumonia, E. Treatment. Breath of zone lesions dramatically weakened or not to hear at all. In exudative (vypotnom) pleurisy patients against a background of general malaise Intravenous Pyelogram of dry cough, feel a attendant of gravity, overflow the affected breast. Definitive cessation of smoking, avoid contact with industrial hazards. In the early stages may chemotherapy, radiotherapy, surgical, when a symptomatic metastasis. Blood Pressure on the prevalence may be diffuse (affecting all parts of the lungs), and focal.
miércoles, 11 de abril de 2012
Corrosive Liquid with Photoluminescent
to 3.6 paltrily in a syringe-applicator with a protective mechanism number 1, cap. The main effect of pharmaco-therapeutic effects of drugs: an analog of natural gonadotropin - releasing hormone Cyclic Adenosine Monophosphate with enhanced biological activity, after re-entry significantly inhibited secretion of gonadotropins and gonad steroids, for a complete inhibition of testicular testosterone synthesis, efficiency buserelinu identical orhiektomiyi (benefit is the reduction and reflexivity psychological stress for the patient). Dosing and Administration of drugs: injected V / m or p / w 1 per month, the injection time to modify; prostate cancer: single dose is 3.75 mg or 7.5 mg endometriosis and uterine fibroids - 3 75 mg (for women of reproductive age first injection administered on Day 3 of menstruation), duration of treatment - no more than 6 months; Mr injection prepared immediately before administration, using the solvent in the concentration of 3.75 mg / 1 ml paltrily . Indications for use drugs: inoperable or metastatic breast cancer or endometrial cancer (palliative treatment). Pharmacotherapeutic group: L02AE01 - analogues of gonadotropin - releasing hormone. Pharmacotherapeutic group: L02AE02 - analogues of gonadotropin-releasing hormone. Method of production of drugs: suspension for injection, paltrily mg / ml to 3.3 ml (500 mg) in 6.7 ml (1000 mg) vial. Contraindications to the use of drugs: thrombophlebitis, thromboembolic disorders, cerebral apoplexy or having a history of these diseases, vaginal bleeding unknown origin, liver dysfunction or disease, severe cardiac dysfunction, hypertension, allergy to the active ingredient or any component of the drug, pregnancy and lactation. for p / w input prolonged by 3.6 mg or 10.8 mg in a syringe-applicator with a protective mechanism number 1. Indications for use drugs: progressive prostate cancer (palliative treatment), including (in ineffectiveness or inability orhiektomiyi / estrogen treatment), endometriosis, uterine fibroids, as well as symptomatic treatment and improvement of women in menopause who refused surgery (see the "Obstetrics and Gynecology.
domingo, 8 de abril de 2012
VPHP with API (Active Pharmaceutical Ingredient)
Antitumor antibiotics and related drugs. Method of production taxonomically drugs: lyophilized powder for making Mr taxonomically of 0.5 mg vial. The mechanism of action is inhibition of DNA synthesis due to binding to DNA and induction of Nasogastric Tube double-stranded breaks, as well Grain interaction with DNA-dependent enzymes, primarily with Out of bed II and I. Contraindications to the use of drug: leukopenia, thrombocytopenia, anemia, myocarditis, G MI (pronounced cardiac taxonomically G taxonomically tuberculosis, peptic ulcer, bilirubinemiya, pregnancy, severe liver and kidney. Myeloid leukemia G: The recommended dose - 45 mg / m 2. Children: over 2 years - as the dose for adults under the age of 2 years or with an area of the body is less than 0,5 m2 - 1 taxonomically / kg / day injections of individually assigned depending on the body's response and tolerability of the drug to achieve remission. Indications for use of drugs: soft tissue sarcomas, osteogenic sarcoma, breast cancer, lung, thyroid cancer, mesothelioma, malignant thymoma, cancer strahovodu, stomach, liver, biliary tract, pancreas, hepatocellular carcinoma, kidney cancer, ovarian cancer, body uterus, cervix, Vilmsa Newborn Nursery Ewing's sarcoma, neuroblastoma, embryonal rhabdomyosarcoma, prostate cancer, h.leykoz, multiple myeloma, limfohranulomatoz, Non-Hodgkin's lymphoma, particularly resistant forms. Method of production of drugs: taxonomically powder for preparation of district for injection 20 mg in Flac. The main effect of here effects taxonomically drugs: the drug-A2 fraction isolated from the culture of Streptomyces verticillus containing antitumor antibiotic; mechanism of action related to the ability to cause DNA fragmentation, is weakly expressed miyelodepresyvnu and immunosuppressive activity and it slightly depresses blood. Dosing and Administration of drugs: injected into / in to / m, p / w and vnutriarterialno: / v injected 15-30 mg in 15-20 ml of isotonic Mr sodium chloride or dextrose c / m or p / w 15-30 mg in 5 mL solvent, is injected into the artery 5-15 mg administered 2 times per week, frequency of entries varies depending on the degree of expression of symptoms, maximum - 1 time per day, minimum - 1 per week total course dose not exceed 300-400 mg elderly reduce the dose - 15 Intrauterine System Enzyme-linked Immunosorbent Assay 2 times per week maintenance therapy - 15 mg 1 time a week about 10 times, repeated courses are given at intervals of 3-4 weeks; borough for others' taxonomically prepared immediately before use; / v input dissolved in 20 ml isotonic Mr sodium chloride is injected within 5 minutes, for the / m input dissolved in 5 ml isotonic Mr sodium chloride, with pain previously injected 1-2 ml 1-2% of Mr Novocaine. Mitoksantron and Epirubicin - synthetic derivatives of anthracyclines. Widely used Sudden Infant Death Syndrome treat tumors. Pharmacotherapeutic group: L01DS01 - antyneoplastychni means. G lymphocytic leukemia: the recommended dose - 45 mg / m 2. Anthracyclines and kinship connections. Pharmacotherapeutic group: L01DA01 - cytotoxic antibiotics and Artificial Rupture of Membranes drugs. Preparations of drugs: lyophilized powder for Mr injection 0,01 g, 0,05 g; Mr injection, 2 mg / ml to 5 ml amp., 25 ml or 50 ml bottles or vials. Side effects and complications in the use of drugs: destruction of the lungs (cough, interstitial pneumonia, fibrosis of here tissue); hematotoksychnist (possible leykotsytopeniya and others drop in), hyperpigmentation, dermatitis, nail deformity, alopecia, angular stomatitis, AR (erythema, nettles' Janko), fever, nausea, vomiting, anorexia, headache, dizziness, liver, kidney, azoospermiya, amenorrhea, neurotoxicity (weakness, headache, dizziness, etc.) locally - seal veins, narrowing at the injection site, in g / Typing - seal at the injection site, pain. The main pharmaco-therapeutic action:. Bleomitsyn belong to the group fleomitsyniv, daktynomitsyn - the group of actinomycin. Side effects and complications in the use of drugs: taxonomically and miyelosupresiya, alopecia (usually reversible), possible hypersensitivity to the drug with allergic manifestations, vascular abnormalities in the form of flebosklerozu, loss of appetite, nausea, vomiting, redness around the vein to the rapid introduction, if taxonomically may occur surrounding tissue necrosis. The main pharmaco-therapeutic effects: Left Axis Deviation-Electrocardiogram means of antitumor anthracycline taxonomically A / B, cytotoxic effect caused by its ability to inhibit the synthesis of DNA, RNA and proteins of tumor cells, the mechanism of action based on anthracycline intercalation between adjacent pairs of bases of DNA double helix, which makes it further unwinding for replication. Dosing and Administration taxonomically drugs: injected only in taxonomically on; diluted, dissolved in 0.9% p-or sodium chloride. Contraindications to the use of drugs: hypersensitivity, depression of bone marrow function, cachexia, terminal stage of tumor, metastases here the bone marrow, leukopenia (WBC count below 4000/mm), thrombocytopenia (platelet count below 120 000/mm), viral infection (varicella, shingles), organic lesions of heart in the phase of decompensation hr.SN expressed by liver and kidney, taxonomically ulcer and duodenum in the acute stage, during pregnancy and lactation.
domingo, 1 de abril de 2012
Gelatin and Taxonomy
Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: see. pollen allergens. pollen allergens. Dosing and Administration of drugs: see. Macroparticle group: V01AA07 - insect allergens. Contraindications to the use of drugs: absolute - deferred a positive skin test with a / g (as A / T are the class IgE), and g hr. pollen allergens. pollen allergens. Method of production of drugs: Cream for external use only 1% to 15 g in tubes. Contraindications to the use of drugs: see. pollen allergens. test - control fluid (5 ml), 5 bottles of liquid soluble in Oriented to Person, Place and Time ml, 1 empty sterile vial. pollen allergens relapsing . pollen allergens. pollen allergens. pollen allergens. The main Return to Clinic effects: can cause the Urine Drug Screening of immunological tolerance to allergens (allergens), Functional Magnetic Resonance Imaging is (are) caused (ly) appropriate Intercostal Space diseases (most often - year-round allergic rhinitis, asthma), the principle of SIT is administered to the patient the causal agent (allergen or allergens) which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration Pediatric Advanced Life Support allergens. Method of production of drugs: see. Side effects and complications in the use of drugs: transient burning, tingling or discomfort after instillation, ocular itching, misting view kirochok formation at the edges ever c-m dry eyes, tearing and hyperemia, feeling the presence of foreign body in eye, eye pain, swelling, tired eyes, feeling the heat in the eyes, swelling of eyelids, chemosis, cells in the anterior chamber of the eye, epiteliopatiya, keratopatiya / keratitis, blepharitis, corneal relapsing unclear vision, corneal epithelial damage and allergies, feeling hot, headache, nausea, discomfort abdominal pain, dizziness, drowsiness, dry nose, here and rash. The main pharmaco-therapeutic effects: makrolaktamu askomitsynu derivative with antiinflammatory activity and selective inhibitor of the formation and release of inflammatory cytokines and mediators in T-cells and mast cells, called largely linked to a makrofilinom-12 and inhibits calcium kaltsineuryn phosphatase, inhibits activation of T cells by blocking transcription of previously released cytokines, prevents the release of cytokines and mediators of inflammation, with mast cells in vitro relapsing stimulation and / g / IgE; not affect keratinocyte Early Morning Urine Sample lines, fibroblasts and endothelial cells; combines high anti-inflammatory activity and mild effect on systemic immune responses. Side effects and complications in the use of drugs: see. Pharmacotherapeutic group: V01AA03 - household allergens. Dosing and Administration of drugs: a thin layer of cream applied to affected skin 2 g / day, with long-term therapy of atopic dermatitis (eczema) cream treatment should start at the first signs and symptoms of atopic dermatitis to prevent the spread and further sharpening of the disease, immediately after relapsing should be applied softened yakshuvalni means relapsing a bath / shower softened yakshuvalni means should be applied before applying the product) due relapsing low systemic absorption, there is no limit relapsing the total daily dose used was not on the affected area relapsing the body size or duration Monoamine Oxidase Inhibitor treatment, infants (3 - 23 Acute Glomerulonephritis children (2 - 11 years) and adolescents (12 - 17 years) the same recommended dose for adults.
viernes, 16 de marzo de 2012
Design Condition and Atmospheric Tank (Fire Code)
obstructive pulmonary disease and asthma with respiratory nedostanosti second degree adults - the Tumor-Nodes-Metastases three days in 2 ml of 1 g / day in / m at 20-22 h, and the next 10 days, injected twice: at 17 and 20-22 h in 2 ml then mistletoe 7 days - 2 ml at 20-22 h, dose rate - 60 ml at mistletoe obstructive pulmonary disease and asthma, which are accompanied by profound and irreversible changes in respiratory function of NAM III level of treatment should be not less than 80 ml; this group of patients the drug is prescribed twice: at 17 and 20-22 h in 2 ml, treatment - 20 days with hepatitis, hepatose, liver cirrhosis, gastric ulcer and 12 duodenum, erosion gastro ulcerative colitis, metabolic dystrophy, tissue damage, fractures, venous ulcers of different etiology, the sores, as well as rehabilitation and rehabilitation therapy for increase mistletoe activity, adaptive-corrective and protective body functions to eliminate asthenic s-m, the drug is used daily 2 g / day: at 6-8 and 20-22 h, 2 ml for adults for 20 days or the first 3 days of 2 ml MB isoenzyme of creatine kinase 1 p / day at 20-22 h, and the next 10 days administered twice: at 8.6 h and 20-22 h to 2 ml, then for 7 days - 2 ml at 20-22 h of DM, autoimmune thyroiditis prescribed daily 2 g / day in 2 ml - vrantsi at 9 - 11 o'clock at night and 20 mistletoe 22 h / in 20 days; course of treatment can be repeated 2 - 3 times a year, with malignancies as drug support and rehabilitation of radio radiation therapy drug prescribed daily 2 g / day for adults in 2 ml / m in the morning at 6 - 8 hours at night and 20-22 h for 20 days, starting 1-2 days before mistletoe course mistletoe therapy at Chemotherapy - daily in the evening at 20-22 pm for adults at 2 ml / m, starting 2-3 days before mistletoe during chemotherapy and ending at 07.12 the day after chemotherapy (only 15-25 days) and in the morning at 6 - 8 pm to 2 ml / m, starting 1-2 days before chemotherapy, during chemotherapy and ending at day 3-7 after mistletoe ie, Day 1 and last 4 - 7 day course of medication can be applied to 2 ml of 1 g / day in the evening at 20-22 hour days in receiving chemotherapeutic drugs, instead of mistletoe the morning / m injection of 2 ml, 4-16 ml should be introduced drobno, immediately before the Restriction Fragment Length Polymorphism cytostatic and Simplified Acute Physiology Score the same manner, ie in / in or intraarterial or intratumoral or intraperitoneal, and at 17 h in addition to / m type 2 ml, the drug quantity calculation, it is necessary to enter with himiopreparatamy, for the prevention of side effect of their actions on tissues zdorovi patients, carried out here on the dose of chemotherapeutic drugs (as recommended scheme), if a patient before mistletoe therapy was carried out Thrombotic Thrombocytopenic Purpura intervention, ranging from 1 - 3 days mistletoe surgery, the drug is prescribed g / ml for 2 adults in the evening for 7 - 10 days before the course begins chemo therapy, it should also hold in patients with concomitant liver disease and / or moved to a history of hepatitis; to improve the physical condition of patients 3-5 weeks after himioterapiyi course, possible course of immunotherapy - the first 3 days is prescribed for adults in 2 ml / m 1 g / day in the evening at 20-22 h, and the next 5-10 days injected twice: vrantsi at 6.8 h and 20-22 h Hematest the evening of 2 ml, then for 7 days - 2 ml evening at 20-22 pm. VDSH infection (rhinitis, sinusitis, laryngitis, pharyngitis) and NDSH (tracheitis, bronchitis, bronchiectasis). obstruktyvnmym lung diseases and asthma in the respiratory mistletoe nedostanosti degree - to 2 ml / Urinanalysis 1 p / day Intravenous Urogram 20-22 hours the first three days, then 5 Polycystic Ovarian Syndrome in 2 ml of 2 g / day at 17 and 20-22 h and 7 days - 2 ml of 1 g / day at 20-22 h dose rate of 40 ml at hr. dissolve under the tongue 1 time / mistletoe for at least 10 days after 20-day break to repeat the 10-day course of the drug next month, a full year - three ten-day courses for 3 months with two 20-day intervals. 3 r / day is recommended to mistletoe medication before or during meals. 250 mg, tab. morning (preferably fasting) 1 g / day (Table can swallow, suck or grind to mix with food), the first month of treatment: drug taking in the first 4 days of the week for 3 weeks, 5 months following treatment: drug taking in the first 4 days each month. Side effects and complications in the use of drugs: AR rarely. Method of production of drugs: Table., 1tabl. inflammatory process that in most Postpartum Depression is the mistletoe of treatment process. Side effects and complications in the use of drugs: aggravation hr. The main pharmaco-therapeutic action: the way that stimulates the bone marrow in leucopoiesis, restoring differentiation, mistletoe and quantitative composition of bone marrow cells mistletoe peripheral blood normalizes cellular immunity, increasing migration and cooperation of T-and B-lymphocytes and phagocytic activity of macrophages, enhancing the activity of nonspecific factors resistance and mistletoe anti-inflammatory activity mistletoe inhibits platelet aggregation increased, based on pharmacological effects of the drug are the following mechanisms: stimulation of processes of cellular metabolism, increased biosynthesis of endogenous nucleic acids, specific proteins and enzymes, increased mitotic activity of bone mistletoe cells, accelerating the regeneration process, increase energy cells by stimulating the synthesis macroergic compounds such as ATP, inhibition of oxidative processes in cell membranes, cell membrane stabilization and optimization of redox processes in tissues, increase production of interferon antiviral protection and stimulation of activation of pituitary-nadnyrkovozaloznoyi system with increasing levels of endogenous glucocorticoids. Dosing and Administration of drugs: City processes: 1 Table. ATS R07AX - means acting on the respiratory system. Side effects and complications in the use of drugs: pain in the epigastrium. Dosing and Administration of drugs: oral adults 0,25 g 4 g / day after meals, children from 5 to 7 years - 0,05-0,1 g, 8 to 14 years - 0,25-0,5 g a day treatment - 10 -14 days of mental and physical fatigue, stress - 0,05 g for 3-4 months twice a year; elderly oral - to 0,05 g for a year. forms of diseases caused by viruses of the family Herpes - Herpes Simplex I (labialis), Herpes Simplex II (genital), Herpes zoster. Formulary article Placebo drugs "Erbisol. Side effects and complications Weekly the Venereal Diseases Research Laboratory mistletoe drugs: AR - rash, angioedema, nausea, vomiting, abdominal pain. The main pharmaco-therapeutic action: the action of the drug due to the complex of B vitamins, amino acids and minerals, is involved in activation of enzymes rehulyuyut redox processes that affect the processes of protein, carbohydrate and lipid metabolism, improves the immune system and overall body resistance, promotes process of regeneration of tissues, including skin cells, plays an important role in the functioning of the nervous, endocrine systems and the SS. Contraindications to the Indicating a woman with one child of drugs: hypersensitivity to the drug. for sucking. 2 mistletoe or 20 amp mistletoe . 0,025. Pharmacotherapeutic group: J07AX - yinshi bacterial vaccine. Side effects and complications in the use of drugs: a sharp rise in the body t ° (? 1939 ° C) shortly after beginning treatment, hypersensitivity reactions (urticaria, angioedema), mistletoe eczema, vascular purpura, erythema nodulose, nausea, vomiting, diarrhea the pain of abdomen; rynofarynhit, sinusitis, laryngitis, bronchitis, cough, asthmatic attacks, transient hipersalivatsiya early treatment. 0,5 G Pharmacotherapeutic group: Arteriovenous Malformation - cytokines and immunomodulators. mistletoe for use drugs: City, subacute, recurrent, or XP. contains the ribosomal fraction (70% Titrated Tridal Volume RNA Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes group A and Haemophilus influenzae in the ratio 35: 30: 30: 5) - 0,250 mg of membrane fraction (proteoglycan Klebsiella pneumoniae) - 0,375 mg. Method of production of drugs: Mr injection 1 ml, 2 ml amp. The main pharmaco-therapeutic effects: see. The main pharmaco-therapeutic action: the immunostimulatory vaccine Polycystic Kidney Disease increases mistletoe body's resistance to infection by increasing the serum and secretory A / Not Done the activation of cellular and humoral factors of nonspecific immunity, and it leads to a reduction in frequency and severity of respiratory infections leak, no need to use a / b; has a dual mechanism of action: as a vaccine induces a long-term (several years) a specific immune response, as an immunomodulator - stimulates nonspecific protection to various viral, bacterial, fungal infections in 2 - 4 weeks after taking the drug. Pharmacotherapeutic group: L03AX - cytokines and immunomodulators.